Surajit Banerjee

Surajit Banerjee

Auto-generated profile, based on publicly available information

Surajit Banerjee

Cornell University

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2014 in Nature
Verified
Journal Article
Closed access
PDF file
TAThorsten Althoff
Thorsten Althoff
RHRyan E. Hibbs
Ryan E. Hibbs
SBSurajit Banerjee
Surajit Banerjee
EGEric Gouaux
Eric Gouaux

25 September 2011 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
KDKelsey C Duggan
Kelsey C Duggan
DHDaniel J Hermanson
Daniel J Hermanson
JMJoel Musee
Joel Musee
JPJeffery J Prusakiewicz
Jeffery J Prusakiewicz
JSJami L Scheib
Jami L Scheib
LMLawrence J Marnett
Lawrence J Marnett

14 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
NMNicholas H. Moeller
Nicholas H. Moeller
KSKe Shi
Ke Shi
ÖDÖzlem Demir
Özlem Demir
CBChristopher Belica
Christopher Belica
SBSurajit Banerjee
Surajit Banerjee
HAHideki Aihara
Hideki Aihara
Significance: SARS-CoV-2 nonstructural protein 14 (nsp14) exoribonuclease (ExoN) plays important roles in the proofreading during viral RNA synthesis and the evasion of host immune responses. We used X-ray crystallography, molecular dynamics simulations, and biochemical assays to investigate the structure, dynamics, and RNA-binding mechanisms of nsp14-ExoN and how its activity is regulated by another viral protein, nsp10. We also demonstrated that nsp14-ExoN can collaborate with the viral RNA polymerase to enable RNA synthesis in the presence of a chain-terminating drug, biochemically recapitulating the proofreading process. Our studies provide mechanistic insights into the functions of a key viral enzyme and a basis for future development of chemical inhibitors.

25 May 2015 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
MMMark W Murphy
Mark W Murphy
JLJohn K Lee
John K Lee
SRSandra Rojo
Sandra Rojo
MGMicah Gearhart
Micah Gearhart
KKKayo Kurahashi
Kayo Kurahashi
VBVivian J Bardwell
Vivian J Bardwell
DMRT transcription factors, key regulators of metazoan sexual development, use a unique DNA binding mode critical for male-to-female sex reversal in humans. DMRT transcription factors are deeply conserved regulators of metazoan sexual development. They share the DM DNA-binding domain, a unique intertwined double zinc-binding module followed by a C-terminal recognition helix, which binds a pseudopalindromic target DNA. Here we show that DMRT proteins use a unique binding interaction, inserting two adjacent antiparallel recognition helices into a widened DNA major groove to make base-specific contacts. Versatility in how specific base contacts are made allows human DMRT1 to use multiple DNA binding modes (tetramer, trimer and dimer). Chromatin immunoprecipitation with exonuclease treatment (ChIP-exo) indicates that multiple DNA binding modes also are used in vivo. We show that mutations affecting residues crucial for DNA recognition are associated with an intersex phenotype in flies and with male-to-female sex reversal in humans. Our results illuminate an ancient molecular interaction underlying much of metazoan sexual development.

1 March 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SXShu Xu
Shu Xu
DHDaniel J. Hermanson
Daniel J. Hermanson
SBSurajit Banerjee
Surajit Banerjee
KGKebreab Ghebreselasie
Kebreab Ghebreselasie
GCGina M. Clayton
Gina M. Clayton
LMLawrence J. Marnett
Lawrence J. Marnett
Oxicams are widely used nonsteroidal anti-inflammatory drugs (NSAIDs), but little is known about the molecular basis of the interaction with their target enzymes, the cyclooxygenases (COX). Isoxicam is a nonselective inhibitor of COX-1 and COX-2 whereas meloxicam displays some selectivity for COX-2. Here we report crystal complexes of COX-2 with isoxicam and meloxicam at 2.0 and 2.45 angstroms, respectively, and a crystal complex of COX-1 with meloxicam at 2.4 angstroms. These structures reveal that the oxicams bind to the active site of COX-2 using a binding pose not seen with other NSAIDs through two highly coordinated water molecules. The 4-hydroxyl group on the thiazine ring partners with Ser-530 via hydrogen bonding, and the heteroatom of the carboxamide ring of the oxicam scaffold interacts with Tyr-385 and Ser-530 through a highly coordinated water molecule. The nitrogen atom of the thiazine and the oxygen atom of the carboxamide bind to Arg-120 and Tyr-355 via another highly ordered water molecule. The rotation of Leu-531 in the structure opens a novel binding pocket, which is not utilized for the binding of other NSAIDs. In addition, a detailed study of meloxicam·COX-2 interactions revealed that mutation of Val-434 to Ile significantly reduces inhibition by meloxicam due to subtle changes around Phe-518, giving rise to the preferential inhibition of COX-2 over COX-1.

5 November 2012 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
Pil Seok ChaePil Seok Chae
Pil Seok Chae
RRRohini R. Rana
Rohini R. Rana
KGKamil Gotfryd
Kamil Gotfryd
SRSøren G. F. Rasmussen
Søren G. F. Rasmussen
AKAndrew C. Kruse
Andrew C. Kruse
SGSamuel H. Gellman
Samuel H. Gellman
The development of a new class of surfactants for membrane protein manipulation, “GNG amphiphiles”, is reported. These amphiphiles display promising behavior for membrane proteins, as demonstrated recently by the high resolution structure of a sodium-pumping pyrophosphatase reported by Kellosalo et al. (Science, 2012, 337, 473).